- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bile Duct Cancer in Hong Kong
Total 1017 results
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruitingBladder CancerUnited States, Japan
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminatedLung CancerUnited States
-
Rutgers, The State University of New JerseyRecruitingCardiac Toxicity | Early-stage Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerCanada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
-
Myriad Genetic Laboratories, Inc.Recruiting
-
Institut de Recherche pour le DeveloppementNational Cancer Institute, France; Fondation de FranceCompletedHPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study (PapilloV)Cervical CancerThailand
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingAdvanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States, Canada, Australia, Hong Kong, Korea, Republic of
-
Xoft, Inc.TerminatedBreast CancerUnited States
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Spectrum Pharmaceuticals, IncActive, not recruitingBreast Cancer | NeutropeniaUnited States
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
HUYABIO International, LLC.RecruitingCancer | Colorectal Cancer | Lung Cancer | Solid Tumor | Non Small Cell Lung Cancer | Colon Cancer | Cancer of PancreasUnited States, Puerto Rico
-
OncotechUnknown
-
Aristotle University Of ThessalonikiNot yet recruitingMedullary Thyroid CancerChina, Switzerland, Spain, Greece, United States, Austria, Belgium, Brazil, Bulgaria, Colombia, Croatia, France, India, Iraq, Italy, Jordan, Morocco, Poland, Serbia, Slovakia, Thailand, Turkey, Ukraine, Vietnam
-
Taiho Oncology, Inc.CompletedBreast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR TumorsFrance, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustralia, Belgium, France, Italy, Hong Kong, Canada, Denmark, Taiwan, Russian Federation, United Kingdom, Spain, Hungary, Czech Republic, Poland, Germany, Netherlands
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
RAPT Therapeutics, Inc.Merck Sharp & Dohme LLCActive, not recruitingAdvanced CancerHong Kong, United States, Australia, Korea, Republic of, Taiwan, Thailand
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Translational Oncology Research InternationalGenentech, Inc.CompletedColorectal CancerUnited States
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Taiwan, Brazil, Argentina, Hong Kong
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
Novartis PharmaceuticalsRecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | KRAS G12C Mutant Solid Tumors | Carcinoma, ColorectalUnited States, Japan, Australia, Germany, Italy, Spain, Canada, Denmark, Korea, Republic of, Taiwan, Belgium, Hong Kong, China, France, Singapore, Netherlands
-
Translational Oncology Research InternationalNational Cancer Institute (NCI); University of California, Los AngelesCompletedGastric Cancer | Esophageal CancerUnited States
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
BioAtla, Inc.RecruitingNon-Small-Cell Lung CancerUnited States, Hong Kong, Taiwan, Spain, Greece, Germany, Italy, Poland
-
Eagle Pharmaceuticals, Inc.CompletedCancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is AppropriateUnited States
-
Hoffmann-La RocheActive, not recruitingEsophageal CancerKorea, Republic of, China, Hong Kong, Thailand, Taiwan
-
Hoffmann-La RocheCompletedNon-small Cell Lung CancerBelgium, Italy, Portugal, Spain, Germany, Turkey, France, Hong Kong, Korea, Republic of, Poland, Russian Federation, Hungary, Norway, Bulgaria, Slovakia
-
Merck KGaA, Darmstadt, GermanyCompletedPreviously Untreated Metastatic Colorectal CancerFrance, Italy, Poland, Germany, Hong Kong, Austria, Brazil, Israel, Greece, Argentina, Thailand, Belgium, Australia, Mexico
-
AstraZenecaRecruitingHepatocellular Carcinoma | Biliary Tract CancerChina, Spain, Korea, Republic of, Italy, United Kingdom, United States, Japan, Taiwan, Hong Kong
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
AstraZenecaParexelRecruitingCancerChina, Taiwan, France, United Kingdom, Korea, Republic of, Malaysia, Thailand, Poland
-
Hoffmann-La RocheCompletedBiliary Tract CancerUnited States, Korea, Republic of, United Kingdom, Hong Kong, Spain, Italy, Turkey, China, Taiwan, Russian Federation, Poland, Thailand, Ukraine
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
Jennerex BiotherapeuticsCompletedHCC | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan
-
Third Military Medical UniversityUnknown
-
Eli Lilly and CompanyCompletedAdvanced CancerPuerto Rico, United States
-
AmgenRecruitingSmall Cell Lung CarcinomaUnited States, Spain, Austria, Switzerland, United Kingdom, France, Australia, Germany, Japan, Taiwan, Poland, Hong Kong, Netherlands
-
Xcovery Holdings, Inc.Active, not recruitingNon-small Cell Lung CancerSpain, United States, China, Korea, Republic of, Hong Kong, United Kingdom, Poland, Israel, Germany, France, Argentina, Australia, Brazil, Canada, Czechia, Italy, Netherlands, Russian Federation, Turkey, Belgium
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
Gilead SciencesActive, not recruitingMetastatic Colorectal CancerUnited States, Spain, Australia, Hong Kong, France, Belgium, Canada, Puerto Rico, Germany, Italy
-
CG Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingNon Muscle Invasive Bladder CancerUnited States, Korea, Republic of
-
Eisai Inc.CompletedNon-small Cell Lung CancerUnited States, Hong Kong, Taiwan, Korea, Republic of, Singapore, Thailand, Malaysia
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
Taiho Pharmaceutical Co., Ltd.CompletedCervical CancerJapan, Korea, Republic of, Taiwan
-
Bristol-Myers SquibbCompletedVarious Advanced CancerUnited States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, United Kingdom
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerFrance, Hong Kong, Korea, Republic of, Russian Federation, Spain, United States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Cyprus, Czech Republic, Egypt, Estonia, ... and more